Background People with cancer are known to be at increased risk of venous thromboembolism
(VTE), and this risk is believed to vary according to cancer type, stage of disease, and …

Venous thromboembolism is common in patients with cancer. However, no management
guidelines exist for venous thromboembolism specific to patients with advanced progressive …

… The objectives of this systematic review and meta-analysis were to evaluate the incidence
… This meta-analysis found that VTE occurs in a relevant proportion of patients hospitalized for …

… trials assessing patients with acute venous thromboembolism only and those … thromboembolism
were not included in this analysis. A prior systematic review and network meta-analysis …

… for venous thromboembolism in both UC and CD patients. … This meta‐analysis showed
that inflammatory bowel disease is … two‐fold increase in the risk of venous thromboembolism. …

… that our meta‐analysis is representative of patients with COVID‐19 requiring hospitalization,
as our systematic review confirmed the previously reported sex differences in patients with …

… We performed this meta-analysis to assess venous thromboembolism risk in patients with …
Nine observational studies met our inclusion criteria and were included in the data analysis. …

… of thromboembolism has been increasingly reported. The aim of this systematic review was
to explore the incidence of venous and arterial thromboembolism among COVID-19 patients …

… patients suffering from acute venous thromboembolism (VTE). The role of direct-acting oral
anticoagulants (DOACs) for the treatment of VTE in cancer patients… network meta-analysis, we …

The risk of venous thromboembolism (VTE) may be increased in patients with liver diseases.
A systematic review and meta-analysis were conducted to analyze the epidemiology of VTE …